Heerma Peter

CIK 00017896171 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001789617

Recent Transactions

50 trades

Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-03−1,078→ 117,993 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-31$35.00/sh−5,591→ 119,071 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-28$30.00/sh−2,662→ 124,662 total
Gift
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-09-23−891→ 127,324 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-05$21.05/sh−1,771→ 128,215 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-05-02−4,920→ 4,920 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-02+4,920→ 129,986 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-12$23.53/sh−2,568→ 125,066 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−3,074→ 127,634 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-02-10−8,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-10+8,000→ 130,708 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$20.12/sh−5,166→ 122,708 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+21,500→ 127,874 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+58,000→ 58,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$18.94/sh−1,584→ 106,374 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-09$11.52/sh−2,191→ 107,958 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-05+6,750→ 110,149 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.53/sh−4,195→ 99,503 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-01-31+65,000→ 65,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-31+25,000→ 103,698 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-23$9.07/sh−1,559→ 78,698 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-10-03$8.25/sh−3,091→ 80,257 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$21.75/sh−1,779→ 82,069 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+20,250→ 83,848 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2023-01-31+6,750→ 6,750 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+54,500→ 54,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.90/sh−1,550→ 63,598 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-10-04$25.68/sh−3,042→ 65,148 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31+9,840→ 68,422 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2022-01-31+8,000→ 8,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2022-01-31+39,360→ 39,360 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2022-01-31+9,840→ 9,840 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31$27.40/sh−1,125→ 67,297 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-24$24.98/sh−1,875→ 58,582 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-10-04$24.77/sh−3,058→ 60,457 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-17$17.12/sh−1,407→ 63,515 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-13+4,500→ 64,922 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-08$31.58/sh−1,125→ 59,344 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-05$31.41/sh−1,125→ 60,469 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03$28.91/sh−563→ 57,094 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03+4,500→ 61,594 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-02$30.75/sh−563→ 57,657 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2021-01-21+57,500→ 57,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-01-21+15,000→ 58,220 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2020-10-05$19.35/sh−2,188→ 42,329 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2020-10-02$18.90/sh−2,188→ 44,517 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2020-01-31+9,000→ 44,000 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2020-01-31+55,000→ 55,000 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2020-01-31+9,000→ 9,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2019-10-01+35,000→ 35,000 total

Companies

Travere Therapeutics, Inc.
CHIEF COMMERCIAL OFFICER
$TVTX

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov